You are here

Article Text

Article menu
Download PDFPDF
Treatment
Multisystemic therapy improved adherence to blood glucose testing in adolescents with type 1 diabetes

https://doi.org/10.1136/ebn.9.1.14

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Ellis DA, Frey MA, Naar-King S, et al. Use of multisystemic therapy to improve regimen adherence among adolescents with type 1 diabetes in chronic poor metabolic control: a randomized controlled trial. Diabetes Care 2005;28:1604–10.OpenUrlAbstract/FREE Full Text

    Q Does multisystemic therapy increase adherence to blood glucose testing and insulin use, improve metabolic control, and reduce hospital use in adolescents with type 1 diabetes and chronically poor metabolic control?

    METHODS

    Embedded ImageDesign:

    randomised controlled trial.

    Embedded ImageAllocation:

    {concealed}.*

    Embedded ImageBlinding:

    blinded (assessor of reason for hospital visit, {data collectors, and data analysts}*).

    Embedded ImageFollow up period:

    7 months.

    Embedded ImageSetting:

    a diabetes clinic in a tertiary care children’s hospital in Detroit, Michigan, USA.

    Embedded ImagePatients:

    127 English speaking adolescents who were 10–17 years of age (mean age 13 y, 51% girls, 63% African-American) and had type 1 diabetes for ⩾1 year (mean 5 y), an average HbA1c concentration ⩾8% in the previous year, and a most recent HbA1c concentration ⩾8%. Adolescents with moderate to severe mental retardation or …

    View Full Text

    Footnotes

    • ↵* Information provided by author.

    • For correspondence: Dr D A Ellis, Department of Child Psychiatry and Psychology, Children’s Hospital of Michigan, Detroit, MI, USA. dellis{at}med.wayne.edu

    • Source of funding: National Institute of Diabetes and Digestive and Kidney Diseases.